Investigations on noval method for the formulation of solid dispersions part- I Formulation, characterization and selection

Rakesh Kumar Sharma, Anil Kumar Middha

DOI: http://dx.doi.org/10.5138/09750215.2173

Abstract


The solid dispersions of indomethacin with hydrophilic polymers were prepared by lyophilization. The polymers used in the investigation were HPMC, PVP K30, CBR and PLF 127. The solubility and dissolution of indomethacin from prepared lyophilized solid dispersions were investigated in 0.1 N HCl, purified water and USP-NF dissolution media.  Out of fifteen lyophilized formulations from F1 to F15, five formulations F2, F5, F8, F12 and F14 showed highest solubility in purified water. Formulation F2, F8 failed to comply with the USP-NF dissolution test for indomethacin capsules. Formulation F14 showed maximum dissolution in the respective dissolution media within 60 min.  Sustained drug release was observed for 6 h with formulations F2 and F8 in USP-NF media. The formulations F2, F5, F8, F12 and F14 were characterized by modulated DSC and FT-IR spectroscopy. Some Formulations on stability testing were found physico-chemically stable at accelerated temperature conditions.


Keywords


lyophilization, indomethacin, Solid dispersions, Dissolution, Stability

Full Text:

PDF

References


[1]. Choiu WL, Riegelman S. Oral absorption of griseofulvin in Dogs: increased absorption via solid dispersion in polyethylene glycol 6000. J. Pharm. Sci. 1970; 59: 937-942.

[2]. Ngoc VO CL, Park C, Lee BJ. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Bio Pharm. 2013; 85:799-813.

[3]. Eloy JO, Marchetti JM. Solid dispersions containing ursolic acid in poloxamer 407 and PEG 6000: A comparative study of fusion and solvent methods Powder Technology. 2014; 253:98-106.

[4]. Fahr A, Liu X. Drug delivery strategies for poorly water soluble drugs. Expert Opin Drug Deliv. 2007; 4: 403-416.

[5]. Oshima T, Sonoda R, Ohkuma M, Sunada H. preparation of rapidly disintegrating tablets containing itraconazole solid dispersions Chem Pharm Bull. 2007;55: 1557-1562

[6]. Konno H, Taylor LS. Ability of different polymers to inhibit the crystallization of amorphous Felodipine in the presence of moisture. Pharm Res. 2008; 25: 969-978.

[7]. Craig DQM. The mechanism of drug release from solid dispersions in water soluble polymers Int J Pharm. 2002; 231:131-144.

[8]. Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous Felodipine. J Pharm Sci. 2006; 95:2692-2705.

[9]. Curatolo W, Nightingale JA, Herbig SM. Utility of hydroxypropylmethylcellulose acetate succinate for initiation and maintance of drug super saturation in the GI milieu Pharm Res. 2009; 26:1419-1431.

[10]. Overhoff KA, Moreno A, Miller DA, Johnson KP, William RO. III solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing Int J Pharm. 2007;336: 122-132.

[11]. Yanbin H, Guo DW. Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica. 2014; 4:18-25.

[12]. Srinarong P, de Waard H, Frijlink HW, Hinrichs WL. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations Expert Opin Drug Deliv. 2011; 8:1121-1140.

[13]. El-Badry M, Fathy M. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze dried solid dispersions in polyvinylpyrrolidone K30 Drug Dev Ind Pharm. 2006;32: 141-150.

[14]. Dontireddy R, crean AM. A comparative study of spray-dried and freeze dried hydrocortisone/polyvinyl pyrrolidone solid dispersions Drug Dev Ind Pharm. 2011; 37:1141-1149.

[15]. Shibata Y, Fujii M, Suzuki A, Koizumi N, Kanada K, Yamada M, Watanabe Y. effect of storage conditions on the recryatallization of drugs in solid dispersions with crospovidone. Pharm Dev Technol. 2014; 19: 468-474.

[16]. Chauhan H, Kumar AK, Barder T, Medek A, Gu CH, Atef E. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction Pharm Res. 2014;31:500-515

[17]. Curatolo W, Nightingale JA, Herbig SM. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug super saturation in the GI milieu. Pharm Res. 2009; 26: 1419–1431.

[18]. Alonzo DE, Zhang GGZ, Zhou D, Gao Y, Taylor LS. Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution. Pharm Res. 2010:27:608–618.

[19]. Rumondor ACF, Stanford LA, Taylor LS. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm Res. 2009; 26(12): 2599–2606.

[20]. Ghebremeskel AN, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Stability testing of selected solid dispersions Pharm Res. 2006; 23:1928-1936.

[21]. Giraldo MLI, Trasi NS, Taylor LS. Impact of surfactants on the crystal growth of amorphous celecoxibInt j pharm. 2014; 461:251-257.

[22]. Chokshi RJ, Shah NH, Sandhu HK, Malick AW, Zia H. Stabilization of low glass transition temperature indomethacin formulations: Impact of polymer-type and its concentration. J Pharm Sci. 2008; 97:2286–2298.

[23]. Matsumoto T, Zografi G. physical properties of solid molecular dispersions of indomethacin with polyvinylpyrrolidone and polyvinylpyrrolidone-covinylacetate in relation to indomethasone crystallization Pharm Res. 1999;16:1722-1728.

[24]. Alonzo DE, Gao Y, Zhou D, Mo H, Zhang GG, Taylor LS. Dissolution and precipitation behavior of amorphous solid dispersions J Pharm Sci. 2011;31: 500-515

[25]. Goyanes A, Martinez-Pacheco R. New co-processed MCC based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization. Drug Dev Ind Pharm 2013.

[26]. Serajuddin ATM. solid dispersion of poorly water soluble drugs: early promises subsequent problems and recent breakthroughs J Pharm Sci. 1999; 88: 1058-1066.

[27]. Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y. Preparation, characterization and tableting of solid dispersion of indomethacin with crospovidoneInt J Pharm. 2005;293:145-153.

[28]. Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method Int j Pharm. 2005:293:155-164.

[29]. Zahedi P, Lee PI. Solid molecular dispersions of poorly water-soluble drugs in poly (2-hydroxyethyl methacrylate) hydrogels, Eur. J. Pharm. Sci. 2007; 65:320-328.

[30]. Sun DD, Ju TC, Lee PI. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly (2-hydroxyethyl methacrylate) hydrogels. European Journal of Pharmaceutics and Bio pharmaceutics. 2012; 81(1):149-58.

[31]. Singla AK, Chawla M, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A Review Drug Dev Ind Pharm. 2000; 26:913-924.

[32]. Radojcic MT, Pavlovic M, Gazikalovic E, Arandjelovic A, Kovacevic A. A comparative analysis of the influence of different types of carbopol on the release rate of lithium carbonate from matrix tablet VojnosanitPredl. 2012; 69:675-680.

[33]. Ozawa M, Hasegawa K, Yonezawa Y. Preparation of solid dispersion for ethenzamide-carbopol and theophylline-carbopol systems using a twin screw extruder Chem pharm Bull. 2002;50:802-7

[34]. Wang L, Chi FD, Hayase T. Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder Chem Pharm Bull. 2005;53:1240-45

[35]. Tao Jing, sun y, Geoff G, Zhang Z, Yu L. solubility of small molecule crystals in polymers D-mannitol in PVP, Indomethacin in PVP/VA and Nifedipine in PVP/VA Pharm Res. 2009;26:855-864.

[36]. Homayouni A, Sadeghi F, Nokhodchi A, Varshosaz J, Garekani HA. Preparation and characterization of celecoxib solid dispersions: comparison of poloxamer-188 and PVP-K30 as carrier. Iran J Basic Med Sci. 2014;17:322-31

[37]. Gurunath S, Nanjwade BK, Patila PA. Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs. Saudi Pharm J. 2014; 22:246-57.

[38]. Singh A, Van Humbeeck J, Vanden Mooter G. A New Twist in the old story- can compression induce mixing of phase separated solid dispersions? A case study of spray- dried Miconazole-PVP VA 64 Solid dispersions. Pharm Res. 2014.

[39]. Pina MF, Zhao M, Pinto JF, Sousa JJ, Craig DQ. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine. J Pharm Sci. 2014; 103:1214-23.

[40]. Karolewicz B, Gajda M, Owczarek A. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127. Pharmazie. 2014; 69:589-94

[41]. Karolewicz B, Gajda M, Owczarek A. The effect of Pluronic F127 on the physicochemical properties and dissolution profile of lovastatin solid dispersions J Therm Ana and chem. 2016; 123: 2283-2290.

[42]. LaFountaine JS, McGinity JW, Williams RO. Challenges and strategies in thermal processing of amorphous solid dispersions: a review. AAPS Pharm Sci Tech. 2016; 17(1):43-55.

[43]. Guo Z, Lu M, Li Y, Pang H, Lin L, Liu X, Wu C. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions. J Pharm Pharmacol. 2014; 66:285-96.

[44]. Mahmah O, Tabbakh R, Kelly A, Paradkar A. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine. J Pharm Pharmacol. 2014; 66:275-84.

[45]. Indian Pharmacopoeia 2007; 152,609-610

[46]. Sarode AL, Malekar SA, Cote C, Worthen DR. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine. Carbohydr Polym. 2014; 112:512-9.

[47]. Kanno H, Handa T, Alonzo DE, Taylor LS. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine Eur j Pharm Bio pharm. 2008;70: 493-499.

[48]. Rawlinson CF, Williams AC, Timmins P, Grimsey I Polymer-mediated disruption of drug crystallinity, Int. J. Pharm. 1997;336:42–48.

[49]. Murphy C, Pillay V, Choonara YE, Lisa C, Valence M, Chirwa N. Optimization of a Dual Mechanism Gastrofloatable and Gastro adhesive Delivery System for Narrow Absorption Window Drugs AAPS Pharm Sci Tech. 2012;13:1-15.

[50]. Colombo P, Bettini R, Peppas NA. Observation of swelling process and diffusion front position during swelling in hydroxypropyl methyl cellulose (HPMC) matrices containing a soluble drug. J. Control. Release. 1999; 61: 83-91


Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 Rakesh Kumar Sharma, Anil Kumar Middha

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Advanced Research Journals

18K, Street 1st, Gaytri Vihar, Pinto Park, Gwalior, M.P. India

Copyright@arjournals.org (Design) 2009-2016

 

Follow @arjournals on Twitter